A 26-year-old woman presented with a 4-month history of recurrent sinusitis, dyspnea on exertion, nonproductive cough, anorexia, and generalized arthralgias. She had recently noted the appearance of erythematous, nonblanching lesions on both lower legs. Her medical history was unremarkable.
A 26-year-old woman presented with a 4-month history of recurrent sinusitis, dyspnea on exertion, nonproductive cough, anorexia, and generalized arthralgias. She had recently noted the appearance of erythematous, nonblanching lesions on both lower legs. Her medical history was unremarkable.
Physical Examination
Vital signs included a respiratory rate of 24 breaths/min and a temperature of 38.5°C. Head and neck examination showed dried blood in both nostrils and no sinus tenderness. Lung examination revealed scattered rhonchi and no wheezes or rales. There was no synovitis or deformity of the joints. Her skin had several small, red, nonblanching papules on both lower legs. Results of cardiovascular, abdominal, and neurologic examination were normal. A lymph node examination revealed no lymphadenopathy.
Laboratory Findings
Values were as follows: hemoglobin, 9.1 g/dL; hematocrit, 27.3%; WBC count, 17,500/L with 82% polymorphonuclear cells, 11% lymphocytes, 4% monocytes, and 3% band forms; platelet count, 232,000/L; erythrocyte sedimentation rate, 82 mm/h; BUN, 10 mg/dL; creatinine, 0.5 mg/dL; and electrolytes, normal. Urinalysis was negative for protein and blood; microscopic examination revealed no cellular elements or casts. Antinuclear antibodies were undetectable. C3 and C4 levels were normal. Antineutrophil cytoplasmic antibody titer was 1:40 (c-ANCA pattern). Sinus CT showed diffuse mucosal thickening, consistent with chronic sinusitis. Chest radiograph revealed multiple small patches of airspace disease. Chest CT is shown in Figure 1 . 
What is the most likely diagnosis?

Diagnosis: Wegener's granulomatosis
Biopsy specimens of the nasal septum and maxillary sinus revealed necrotizing granulomatous inflammation. Bronchoscopy was remarkable for diffuse mucosal erythema and edema. Endobronchial biopsy specimens also revealed necrotizing granulomatous inflammation, and Gram's, Grocott, and acid-fast stains were negative. Based on these histologic findings, a diagnosis of Wegener's granulomatosis (WG) was made, and therapy with prednisone and cyclophosphamide was initiated.
WG is a systemic disease characterized histologically by necrotizing granulomatous inflammation and vasculitis involving small arteries, veins, and capillaries. The mean age of onset is 40 years, although the disease may occur at any age. WG is uncommon, with an estimated incidence of 3/100,000 population; it occurs with equal frequency in men and women. The disease most commonly affects the upper and lower respiratory tracts, although virtually any organ system may be involved. Constitutional symptoms are common and include fever, malaise, fatigue, anorexia, and weight loss. Upper respiratory tract disease most commonly leads to sinusitis and rhinitis, with nasal congestion, rhinorrhea, epistaxis, mucosal ulceration, nasal septal perforation, and nasal deformity. Involvement of the lower respiratory tract is frequently asymptomatic, and diagnosis is often based on the presence of parenchymal infiltrates or single or multiple pulmonary nodules on chest radiograph or CT. Renal involvement occurs in Ͼ 75% of patients during the course of the disease. Histologically, WG produces a focal and segmental necrotizing glomerulonephritis that may rapidly progress to renal failure. Skin lesions of WG include palpable purpura, subcutaneous nodules, papules, vesicles, and ulcers. Pyoderma gangrenosum and Raynaud's phenomenon have also been reported. Musculoskeletal involvement occurs in about two thirds of patients. Although most patients experience only arthralgias and myalgias, monoarticular or polyarticular arthritis may occur. Eye disease occurs in up to 50% of patients and may lead to proptosis due to retro-orbital pseudotumor, conjunctivitis, keratitis, episcleritis, uveitis, retinal artery obstruction, and optic neuritis. Unusual manifestations of WG include mononeuritis multiplex, stroke, and pericarditis. If untreated, WG is invariably fatal. Therapy with corticosteroids and cyclophosphamide produces improvement or complete remission in most patients.
Common but nonspecific laboratory findings in patients with WG include an elevated erythrocyte sedimentation rate, leukocytosis, thrombocytosis, and a normochromic, normocytic anemia. Antineutrophil cytoplasmic antibody (ANCA) has been identified as a serologic marker for WG but its role in disease pathogenesis has not been determined. Using indirect immunofluorescence of neutrophils, two patterns have been described: a cytoplasmic pattern (c-ANCA) and a perinuclear pattern (p-ANCA). The presence of c-ANCA is highly specific for WG, but its sensitivity varies greatly with disease activity. The presence of p-ANCA is not suggestive of WG but is associated with a variety of other diseases, including microscopic polyangiitis, idiopathic necrotizing and crescentic glomerulonephritis, collagen vascular diseases, and inflammatory bowel disease.
Clinical Course
Despite the resolution of many of her symptoms, the patient developed progressive dyspnea on exertion. Several months after her initial evaluation, pulmonary examination disclosed diffuse inspiratory and expiratory wheezing, and the chest radiograph demonstrated a new right upper lobe atelectasis (Fig 2) . Fiberoptic bronchoscopy revealed diffuse, severe narrowing of the lobar, segmental, and subsegmental airways. The right upper lobe bronchus was narrowed to approxi- mately 1 mm in diameter. There was no erythema, friability, or other signs of active inflammation. The larynx and trachea were normal in appearance. Spirometry revealed severe airflow obstruction, with an FEV 1 of 1.36 L (39% predicted). Despite intensive immunosuppressive and cytotoxic therapy, the patient's dyspnea did not improve. Serial chest radiographs showed persistent right upper lobe collapse with intermittent atelectasis of the left upper lobe. Because of her severe airway disease, the patient was evaluated for lung transplantation.
After approximately a 1-year period of clinical stability, the patient again developed rapidly progressive dyspnea. Repeated spirometry revealed worsening airflow obstruction with an FEV 1 of 0.91 L (27% predicted). In addition, however, there was marked flattening of both the inspiratory and expiratory components of the flow-volume loop (Fig 3) . Fixed upper airway obstruction was suspected, and, as shown in Figure 3 , fiberoptic bronchoscopy confirmed the presence of marked subglottic stenosis. Rigid bronchoscopy was subsequently performed with progressive dilation of the subglottic stricture. Lower airway inspection revealed no changes from the prior examination. Since that time, the patient's dyspnea has, in general, been stable, although she has required several more dilations of the subglottic region.
What is the cause of this patient's airway disease?
Diagnosis: Severe airway involvement by WG Although uncommon, WG can be accompanied by two major forms of airway disease, both of which are illustrated by this case: subglottic stenosis and ulcerating tracheobronchitis. Subglottic stenosis occurs in approximately 15% of patients sometime during the course of disease and results from circumferential inflammation, edema, and fibrosis that typically extends for 3 to 4 cm below the vocal cords. Depending on the degree of narrowing, patients may be asymptomatic or present with hoarseness, stridor, and dyspnea. Subglottic stenosis is often not evident on the chest radiograph but, as illustrated in Figure 3 , usually leads to characteristic changes in the flow-volume loop. Although some patients respond to systemic immunosuppressive therapy, manual dilation, often preceded by tracheostomy, is required in most symptomatic patients. Laser resection is not beneficial, since it usually leads to extensive scarring and stenosis.
Ulcerating tracheobronchitis is characterized by focal or diffuse airway narrowing due to inflammation and edema. Tracheomalacia and bronchomalacia may also occur, leading to further airway compromise. As in this case, intense airway inflammation often leads to cicatricial tracheal or bronchial scarring with marked stenosis. Although 50 to 60% of patients who undergo bronchoscopy will have evidence of lower airway involvement, this represents a highly selected subgroup, and the true incidence of tracheobronchitis is believed to be low. Clinical manifestations include dyspnea, cough, hemoptysis, a prolonged expiratory time, and wheezing. Chest radiography, which may demonstrate airway narrowing or atelectasis, is frequently normal, even in the presence of significant disease. Endobronchial biopsy specimens have been reported to demonstrate findings consistent with or diagnostic of WG in about 50% of patients with active airway inflammation. Therapeutic options in patients with focal narrowing include balloon dilation, laser ablation, stent placement, and surgical resection. The therapy of diffuse, fibrotic airway stenosis is limited to lung transplantation.
As illustrated by this case, tracheobronchial involvement in WG often progresses despite immunosuppres- sive therapy that controls disease activity elsewhere. In addition, the presence and titer of c-ANCA, while useful in assessing the overall disease activity, has been shown to have no predictive value for the presence or activity of tracheobronchial disease.
Therefore, WG must be included in the differential diagnosis of tracheobronchial stenosis. Other causes are listed in Table 1 . With the exception of bronchogenic carcinoma, all of these disorders are uncommon. In most cases, diagnosis depends on histologic examination and/or culture of endobronchial or parenchymal tissue. 
